Efficacy of Actaea racemosa for relieving climacteric complaints

With our predominant focus on the COVID-19 pandemic, it is important that noncommunicable diseases are not neglected in these changing times. Menopause is often associated with challenging symptoms which impact quality of life and individual resiliency. Applicable randomised controlled trials examining the efficacy of Actaea racemosa (Black cohosh) were identified for analysis, and assessed for adherence to the CONSORT Extensions for Herbal Medicinal Interventions. Results suggest Actaea racemosa to have a beneficial effect on reducing climacteric complaints, potentially reducing reliance on conventional medical resources. However inconsistences were noted, requiring further investigation. These findings and clinical practice implications will be presented.